Cara Therapeutics (CARA) & Enteris BioPharma, Inc. Doses First Patient in Phase 1 Trial of Oral KORSUVA™

Enteris BioPharma’s “Feasibility-to-Licensing” Partner, Cara Therapeutics, Doses First Patient in Phase 1…

Future Farm Technologies Inc. (FFRMF) Estimates $3,000,000 USD in Revenue in 2018

Future Farm Estimates $3,000,000 USD in Revenue in 2018 From 10-acre Operating…

Endexx Corporation (EDXC) CEO, Todd Davis Returns

Endexx Corporation CEO, Todd Davis Returns to Uptick Newswire’s “Stock Day” Podcast…

Leafbuyer Technologies, Inc. (LBUY) Continues Growth, Sales Surge 42% in Latest Quarter

Leafbuyer Technologies, Inc. Continues Growth, Sales Surge 42% in Latest Quarter Leafbuyer…

Cara Therapeutics, Inc. (CARA) Doses First Patient in Phase 1 Trial of Oral KORSUVA™

Cara Therapeutics Doses First Patient in Phase 1 Trial of Oral KORSUVA™…

Omni Health, Inc. (OMHE) Announces Upcoming Opening of Functional Medicine Clinic

Omni Health Announces Upcoming Opening of Functional Medicine Clinic With Focus on…